7Baggers
Quarterly
Annual
    Unit: USD2025-09-28 2025-06-29 2025-03-30 2024-12-29 2024-09-29 2024-06-23 2024-03-24 2023-12-24 2023-09-24 2023-06-25 2023-03-26 2022-12-25 2022-09-25 2022-06-26 2022-03-27 2021-12-26 2021-09-26 2021-06-27 2021-03-28 2020-12-27 2020-09-27 2020-06-28 2020-03-29 2019-12-29 2019-06-30 2019-03-31 2018-12-30 2018-09-30 2018-06-24 2018-03-25 2017-12-24 2017-09-24 2017-06-25 2017-03-26 2016-12-25 2016-09-25 2016-06-26 2016-03-27 2015-12-27 2015-09-27 2015-06-28 2015-03-29 2014-12-28 2014-09-28 2014-06-29 2014-03-30 2013-12-29 2013-09-29 2013-06-30 2013-03-31 2012-12-30 2012-09-30 2012-06-24 
      
    		                                                     
      operating activities:
    		                                                     
      net income
    		-3,117,000,000 2,666,000,000 2,812,000,000 3,180,000,000 2,915,000,000 2,108,000,000 2,276,000,000 2,811,000,000 1,629,000,000 1,735,000,000 1,702,000,000 2,273,000,000 2,923,000,000 3,730,000,000 2,934,000,000 3,399,000,000 2,798,000,000 2,028,000,000 1,762,000,000 2,455,000,000 2,960,000,000 845,000,000 468,000,000 925,000,000 2,149,000,000 663,000,000 1,068,000,000  1,219,000,000 363,000,000 -5,953,000,000 169,000,000 865,000,000 750,000,000 681,000,000 1,599,000,000 1,443,000,000 1,164,000,000 1,496,000,000 1,061,000,000 1,184,000,000 1,052,000,000 1,971,000,000 1,894,000,000 2,237,000,000 1,959,000,000 1,874,000,000 1,501,000,000 1,578,000,000 1,863,000,000 1,903,000,000 1,262,000,000 1,203,000,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                                                     
      depreciation and amortization expense
    		371,000,000 398,000,000 397,000,000 436,000,000 439,000,000 419,000,000 411,000,000 437,000,000 462,000,000 479,000,000 470,000,000 398,000,000 490,000,000 438,000,000 428,000,000 406,000,000 425,000,000 406,000,000 387,000,000 364,000,000 339,000,000 363,000,000 340,000,000 351,000,000 353,000,000 345,000,000 353,000,000  414,000,000 388,000,000 363,000,000 397,000,000 393,000,000 342,000,000 329,000,000 336,000,000 356,000,000 372,000,000 364,000,000 326,000,000 297,000,000 304,000,000 287,000,000 297,000,000 292,000,000 289,000,000 272,000,000       
      indefinite and long-lived asset impairment charges
    		                        0 53,000,000 150,000,000  63,000,000   0 42,000,000 2,000,000 32,000,000 13,000,000 47,000,000 45,000,000 2,000,000               
      income tax provision in excess of (less than) income tax payments
    		   247,000,000                53,000,000                                156,000,000 -261,000,000 
      share-based compensation expense
    		663,000,000 659,000,000 702,000,000 759,000,000 697,000,000 644,000,000 705,000,000 602,000,000 608,000,000 614,000,000 628,000,000 634,000,000 521,000,000 516,000,000 498,000,000 496,000,000 425,000,000 424,000,000 422,000,000 392,000,000                                  
      net gains on marketable securities and other investments
    		-84,000,000 -288,000,000 36,000,000 -45,000,000  -41,000,000 -202,000,000 -71,000,000    -25,000,000    -103,000,000 -515,000,000 -186,000,000 -106,000,000 -195,000,000 -67,000,000 -220,000,000   -331,000,000                             
      impairment losses on other investments
    		20,000,000 52,000,000   13,000,000 4,000,000   12,000,000 19,000,000        8,000,000 15,000,000 1,000,000  12,000,000 265,000,000 72,000,000                              
      other items
    		-34,000,000 46,000,000 -46,000,000 -23,000,000 -4,000,000 -33,000,000 -39,000,000 9,000,000 2,000,000 7,000,000 49,000,000 -33,000,000   -10,000,000 -25,000,000 -9,000,000 -25,000,000 -29,000,000 -19,000,000 -34,000,000 -33,000,000 -49,000,000 -26,000,000 -17,000,000 -154,000,000 -36,000,000  -21,000,000 -11,000,000 57,000,000 132,000,000 -83,000,000 101,000,000 -4,000,000   60,000,000 -13,000,000 13,000,000 1,000,000 1,000,000 -31,000,000 -105,000,000 108,000,000 -53,000,000 33,000,000 -170,000,000 183,000,000 63,000,000 28,000,000 3,000,000 44,000,000 
      changes in assets and liabilities:
    		                                                     
      accounts receivable
    		-900,000,000 308,000,000 -165,000,000 392,000,000 -989,000,000 129,000,000 417,000,000 -325,000,000 665,000,000 -157,000,000 270,000,000 1,694,000,000 -1,850,000,000 285,000,000 -47,000,000 -454,000,000 -626,000,000 394,000,000 799,000,000 -141,000,000 -2,151,000,000 1,229,000,000 -345,000,000 -262,000,000 1,251,000,000 -215,000,000 415,000,000 2,434,000,000 376,000,000 -487,000,000 581,000,000 -83,000,000 670,000,000 -1,822,000,000 131,000,000 -271,000,000 -215,000,000 -392,000,000 646,000,000 112,000,000 100,000,000 165,000,000 173,000,000 -324,000,000 139,000,000 -884,000,000 788,000,000 -235,000,000 -21,000,000 -239,000,000 -185,000,000 -207,000,000 -54,000,000 
      inventories
    		-171,000,000 -169,000,000 91,000,000 111,000,000 -384,000,000 69,000,000 163,000,000 165,000,000 200,000,000 204,000,000 80,000,000 -476,000,000 -936,000,000 -864,000,000 -699,000,000 -638,000,000 -113,000,000 -449,000,000 -122,000,000 62,000,000 -219,000,000 -641,000,000 -280,000,000 -17,000,000 -46,000,000 -31,000,000 -18,000,000 1,448,000,000 2,000,000 81,000,000 162,000,000 -18,000,000 63,000,000 109,000,000 -354,000,000 -218,000,000 90,000,000 -212,000,000 291,000,000 215,000,000 281,000,000 -100,000,000 -303,000,000 -271,000,000 -37,000,000 -84,000,000 237,000,000 399,000,000 -245,000,000 -207,000,000 -247,000,000 -199,000,000 -32,000,000 
      other assets
    		610,000,000 62,000,000 151,000,000 148,000,000 110,000,000 -101,000,000 106,000,000 115,000,000 -1,000,000 -11,000,000 206,000,000 409,000,000 94,000,000 -548,000,000 -308,000,000 -1,504,000,000 -1,688,000,000 99,000,000 37,000,000 -97,000,000 29,000,000 -68,000,000 48,000,000 -119,000,000 -10,000,000 173,000,000 -148,000,000  20,000,000 126,000,000 -56,000,000 58,000,000 4,000,000 123,000,000 -16,000,000 93,000,000 32,000,000 55,000,000 66,000,000 104,000,000 241,000,000 -998,000,000 -140,000,000 -28,000,000 9,000,000 58,000,000 69,000,000 -98,000,000 90,000,000 -150,000,000 -51,000,000 -209,000,000 -21,000,000 
      trade accounts payable
    		339,000,000 -123,000,000 -108,000,000 11,000,000 -9,000,000 271,000,000 179,000,000 241,000,000 172,000,000 306,000,000 -1,094,000,000 -1,264,000,000 88,000,000 -31,000,000 198,000,000 781,000,000 46,000,000 158,000,000 162,000,000 129,000,000 162,000,000 -10,000,000 359,000,000 396,000,000 -94,000,000 230,000,000 -403,000,000  215,000,000 -263,000,000 -248,000,000 498,000,000 134,000,000 -469,000,000 -208,000,000 278,000,000 126,000,000 87,000,000 50,000,000 -139,000,000 -261,000,000 -776,000,000 268,000,000 298,000,000 286,000,000 183,000,000 -148,000,000 -291,000,000 221,000,000 1,000,000 376,000,000 174,000,000 -90,000,000 
      payroll, benefits and other liabilities
    		708,000,000 -170,000,000 -232,000,000 -541,000,000 392,000,000 368,000,000 212,000,000 74,000,000 605,000,000 68,000,000 -386,000,000 -286,000,000 231,000,000 -903,000,000 124,000,000 -495,000,000 286,000,000 657,000,000 -130,000,000 278,000,000 251,000,000 253,000,000 195,000,000 -171,000,000 -1,807,000,000 -151,000,000 -576,000,000  348,000,000 166,000,000 1,000,000,000 1,220,000,000 -1,802,000,000 1,632,000,000 785,000,000 82,000,000 176,000,000 -708,000,000 98,000,000 78,000,000 -1,000,000 -425,000,000 20,000,000 -280,000,000 -235,000,000 240,000,000 -342,000,000 700,000,000 -151,000,000 590,000,000 -387,000,000 71,000,000 -151,000,000 
      unearned revenues
    		59,000,000 70,000,000 21,000,000 -88,000,000 21,000,000 -11,000,000 91,000,000 -81,000,000 60,000,000 -30,000,000 -5,000,000 -81,000,000 -92,000,000 -93,000,000 -61,000,000 -78,000,000 -79,000,000 -18,000,000 2,000,000 -107,000,000 -48,000,000 -45,000,000 -38,000,000 -115,000,000 9,000,000 -60,000,000 -62,000,000  -53,000,000 -50,000,000 -75,000,000 -82,000,000 -69,000,000 4,000,000 -84,000,000 -37,000,000 -319,000,000 86,000,000 -37,000,000 -153,000,000 -162,000,000 -173,000,000 -73,000,000 -90,000,000 -90,000,000 -13,000,000 -99,000,000 45,000,000 -19,000,000 -7,000,000 -4,000,000 -42,000,000 -65,000,000 
      net cash used by operating activities from discontinued operations
    		    0 0 -75,000,000 -16,000,000 -5,000,000 -333,000,000 -33,000,000 -28,000,000                                          
      net cash from operating activities
    		3,996,000,000 2,875,000,000 2,554,000,000 4,587,000,000 2,647,000,000 3,052,000,000 3,554,000,000 2,949,000,000 4,090,000,000 2,657,000,000 1,457,000,000 3,095,000,000 1,446,000,000 2,895,000,000 2,698,000,000 2,057,000,000 1,077,000,000 3,373,000,000 2,911,000,000 3,175,000,000 1,741,000,000 1,872,000,000 1,083,000,000 1,118,000,000 4,909,000,000 794,000,000 356,000,000 -436,000,000 2,053,000,000 516,000,000 1,762,000,000 2,417,000,000 82,000,000 815,000,000 1,379,000,000 2,084,000,000 1,840,000,000 737,000,000 2,739,000,000 1,684,000,000 2,116,000,000 -658,000,000 2,364,000,000 1,619,000,000 2,673,000,000 1,814,000,000 2,781,000,000 2,510,000,000 2,077,000,000 2,216,000,000 1,975,000,000 1,409,000,000 922,000,000 
      investing activities:
    		                                                     
      capital expenditures
    		-407,000,000 -294,000,000 -214,000,000 -277,000,000 -256,000,000 -387,000,000 -184,000,000 -214,000,000 -293,000,000 -306,000,000 -453,000,000 -398,000,000 -634,000,000 -554,000,000 -491,000,000 -583,000,000 -430,000,000 -506,000,000 -483,000,000 -469,000,000 -348,000,000 -418,000,000 -345,000,000 -296,000,000 -248,000,000 -170,000,000 -152,000,000  -214,000,000 -185,000,000 -226,000,000 -262,000,000 -177,000,000 -122,000,000 -129,000,000 -150,000,000 -136,000,000 -125,000,000 -128,000,000 -179,000,000 -366,000,000 -196,000,000 -253,000,000 -230,000,000 -158,000,000 -587,000,000 -210,000,000 -240,000,000 -314,000,000 -289,000,000 -205,000,000 -250,000,000 -399,000,000 
      free cash flows
    		3,589,000,000 2,581,000,000 2,340,000,000 4,310,000,000 2,391,000,000 2,665,000,000 3,370,000,000 2,735,000,000 3,797,000,000 2,351,000,000 1,004,000,000 2,697,000,000 812,000,000 2,341,000,000 2,207,000,000 1,474,000,000 647,000,000 2,867,000,000 2,428,000,000 2,706,000,000 1,393,000,000 1,454,000,000 738,000,000 822,000,000 4,661,000,000 624,000,000 204,000,000  1,839,000,000 331,000,000 1,536,000,000 2,155,000,000 -95,000,000 693,000,000 1,250,000,000 1,934,000,000 1,704,000,000 612,000,000 2,611,000,000 1,505,000,000 1,750,000,000 -854,000,000 2,111,000,000 1,389,000,000 2,515,000,000 1,227,000,000 2,571,000,000 2,270,000,000 1,763,000,000 1,927,000,000 1,770,000,000 1,159,000,000 523,000,000 
      purchases of debt and equity marketable securities
    		-909,000,000 -459,000,000 -2,412,000,000 -914,000,000 -913,000,000 -1,314,000,000 -1,390,000,000 -1,452,000,000 -646,000,000 0 0 -22,000,000 -145,000,000 -333,000,000 -419,000,000 -517,000,000 -449,000,000 -1,266,000,000 -1,944,000,000 -2,248,000,000 -1,365,000,000 -3,536,000,000                                
      proceeds from sales and maturities of debt and equity marketable securities
    		863,000,000 2,737,000,000 1,403,000,000 752,000,000 782,000,000 717,000,000 715,000,000 463,000,000 447,000,000 628,000,000 272,000,000 219,000,000 662,000,000 397,000,000 430,000,000 1,133,000,000 1,073,000,000 1,335,000,000 1,535,000,000 1,612,000,000 1,388,000,000 755,000,000 127,000,000 129,000,000 32,000,000 57,000,000 35,000,000                           
      acquisitions and other investments, net of cash acquired
    		-32,000,000 -370,000,000 -81,000,000 -260,000,000 -20,000,000 -69,000,000 -105,000,000 -60,000,000 -128,000,000 -46,000,000 -32,000,000 -29,000,000 -169,000,000 -4,455,000,000 -50,000,000 -238,000,000 -93,000,000 -48,000,000 -1,098,000,000 -138,000,000 -26,000,000 -31,000,000 -53,000,000 -75,000,000 -67,000,000 -62,000,000 -56,000,000  -22,000,000 -48,000,000 -122,000,000 -143,000,000 -19,000,000 -1,325,000,000 -57,000,000 -149,000,000 -40,000,000 -173,000,000 -450,000,000 -2,689,000,000 -130,000,000 -80,000,000 -98,000,000 -436,000,000 -100,000,000 -32,000,000 -315,000,000 -13,000,000 -47,000,000 -93,000,000 -39,000,000 -156,000,000 -348,000,000 
      proceeds from sales of property, plant and equipment
    		    0 2,000,000 3,000,000 5,000,000 6,000,000 0 10,000,000 111,000,000                        1,000,000    105,000,000              
      proceeds from other investments
    		8,000,000 12,000,000   18,000,000 8,000,000   7,000,000 2,000,000 7,000,000 4,000,000 7,000,000 28,000,000 4,000,000 93,000,000 86,000,000 67,000,000      26,000,000 6,000,000 16,000,000 23,000,000  48,000,000                         
      net cash from investing activities from discontinued operations
    		                                                     
      net cash (used) provided by investing activities
    		    -385,000,000                    -208,000,000      -3,261,000,000            -1,736,000,000           
      financing activities:
    		                                                     
      proceeds from short-term debt
    		0 498,000,000 0 500,000,000 0 0 399,000,000 400,000,000 400,000,000 0 3,210,000,000 1,458,000,000 3,935,000,000 1,603,000,000 752,000,000 710,000,000 701,000,000 606,000,000 760,000,000 819,000,000 562,000,000 1,170,000,000 558,000,000 558,000,000 1,511,000,000 1,513,000,000 1,784,000,000  3,822,000,000 3,447,000,000 2,116,000,000 1,710,000,000 1,735,000,000 2,386,000,000 2,727,000,000 2,316,000,000 2,305,000,000 3,239,000,000 1,089,000,000 1,270,000,000 1,718,000,000             
      repayment of short-term debt
    		0 -498,000,000 0 -500,000,000 0 0 -399,000,000 -400,000,000 -400,000,000 -498,000,000 -2,713,000,000 -1,955,000,000 -3,937,000,000 -1,604,000,000 -752,000,000 -710,000,000 -700,000,000 -606,000,000 -761,000,000 -818,000,000 -561,000,000 -1,169,000,000 -558,000,000 -558,000,000 -1,510,000,000 -1,513,000,000 -1,790,000,000  -2,868,000,000 -3,181,000,000 -1,149,000,000 -1,711,000,000 -2,734,000,000 -2,137,000,000 -2,727,000,000 -2,315,000,000 -2,505,000,000 -2,290,000,000 -1,090,000,000 -1,269,000,000              
      proceeds from long-term debt
    		0        0 0 0 1,880,000,000 0        -1,000,000           0        0              
      repayment of long-term debt
    		0    0    0 0   0        -219,000,000                                 
      proceeds from issuance of common stock
    		203,000,000 0   187,000,000 1,000,000   201,000,000 1,000,000   168,000,000 1,000,000   173,000,000 0   153,000,000 2,000,000 151,000,000 23,000,000 87,000,000 149,000,000 28,000,000  52,000,000 201,000,000 134,000,000 166,000,000 41,000,000 159,000,000 131,000,000 246,000,000 151,000,000 172,000,000 99,000,000 216,000,000 154,000,000 301,000,000 116,000,000 292,000,000 194,000,000 512,000,000 441,000,000 561,000,000 217,000,000 407,000,000 340,000,000 356,000,000 223,000,000 
      repurchases and retirements of common stock
    		-2,444,000,000 -2,849,000,000 -1,748,000,000 -1,750,000,000 -1,303,000,000 -1,303,000,000 -731,000,000 -784,000,000 -400,000,000 -400,000,000 -903,000,000 -1,270,000,000 -500,000,000 -500,000,000 -951,000,000 -1,178,000,000 -771,000,000 -630,000,000 -1,521,000,000 -444,000,000 0 -110,000,000 -1,578,000,000 -762,000,000 -69,000,000 0 -1,019,000,000  -1,000,000,000 -200,000,000 -225,000,000 -315,000,000 -300,000,000 -283,000,000 -444,000,000 -225,000,000 -100,000,000 -1,548,000,000 -2,050,000,000 -2,230,000,000 -5,405,000,000 -1,947,000,000 -1,664,000,000 -1,195,000,000 -1,350,000,000 -1,002,000,000 -1,002,000,000 -3,321,000,000 -1,039,000,000 0 -250,000,000   
      dividends paid
    		-957,000,000 -968,000,000 -938,000,000 -942,000,000 -948,000,000 -949,000,000 -895,000,000 -895,000,000 -893,000,000 -893,000,000 -834,000,000 -842,000,000 -841,000,000 -842,000,000 -764,000,000 -765,000,000 -768,000,000 -767,000,000 -734,000,000 -739,000,000 -734,000,000 -733,000,000 -705,000,000 -710,000,000 -755,000,000 -752,000,000 -750,000,000  -911,000,000 -845,000,000 -844,000,000 -841,000,000 -844,000,000 -783,000,000 -784,000,000 -782,000,000 -781,000,000 -710,000,000 -717,000,000 -738,000,000 -757,000,000 -688,000,000 -697,000,000 -702,000,000 -705,000,000 -589,000,000 -590,000,000 -592,000,000 -604,000,000 -431,000,000 -428,000,000 -425,000,000 -429,000,000 
      payments of tax withholdings related to vesting of share-based awards
    		-237,000,000 -269,000,000 -294,000,000 -315,000,000 -135,000,000 -282,000,000 -145,000,000 -370,000,000 -22,000,000 -167,000,000 -23,000,000 -309,000,000 -15,000,000 -189,000,000 -62,000,000 -500,000,000 -27,000,000 -209,000,000 -52,000,000 -449,000,000 -18,000,000 -94,000,000 -31,000,000 -201,000,000 -82,000,000 -4,000,000 -139,000,000  -77,000,000 -4,000,000 -192,000,000                       
      net cash provided (used) by financing activities from discontinued operations
    		    0                                                 
      net cash used by financing activities
    		-3,436,000,000 -3,971,000,000 -2,781,000,000 -3,008,000,000 -2,199,000,000 -3,449,000,000 -1,580,000,000 -2,041,000,000 -1,117,000,000 -1,988,000,000 -2,543,000,000 -1,015,000,000 -1,192,000,000 -1,960,000,000 -1,598,000,000 -2,446,000,000 -1,402,000,000 -1,608,000,000 -2,143,000,000 -1,645,000,000 -836,000,000 -1,003,000,000 -2,209,000,000 -1,659,000,000 -915,000,000 -644,000,000 -1,887,000,000   -709,000,000 -165,000,000   -666,000,000 -1,104,000,000   -1,157,000,000 -2,665,000,000   -1,213,000,000 -2,203,000,000 -1,563,000,000 -1,976,000,000 -868,000,000 -1,073,000,000    -275,000,000   
      effect of exchange rate changes on cash and cash equivalents
    		-17,000,000 33,000,000 6,000,000 -44,000,000 16,000,000 -9,000,000 -10,000,000 15,000,000 -5,000,000 -11,000,000 19,000,000 27,000,000 -63,000,000 -34,000,000 -8,000,000 -8,000,000 -8,000,000 6,000,000 -12,000,000 41,000,000 20,000,000   14,000,000   -3,000,000  -51,000,000 35,000,000 -3,000,000 20,000,000 34,000,000 11,000,000 -17,000,000 -7,000,000 7,000,000 1,000,000 -5,000,000 -10,000,000 5,000,000 -8,000,000 -7,000,000  4,000,000 -2,000,000 1,000,000  -3,000,000     
      net increase in total cash, cash equivalents and restricted cash
    		                                                     
      total cash and cash equivalents at beginning of period
    		0 0 0 7,849,000,000 0 0 0 8,527,000,000 0 0 0 3,099,000,000 0 0 0 7,116,000,000 0 0 0 6,707,000,000 0 0 0 11,839,000,000 0                             
      total cash and cash equivalents at end of period
    		72,000,000 568,000,000 -1,510,000,000 8,713,000,000 79,000,000 -1,449,000,000 1,025,000,000 8,194,000,000 2,350,000,000 2,395,000,000 -1,291,000,000 5,073,000,000 -99,000,000 -3,975,000,000 566,000,000 6,607,000,000 -283,000,000 1,399,000,000 -1,076,000,000 7,076,000,000 587,000,000 -2,283,000,000 -2,706,000,000 11,109,000,000 3,788,000,000                             
      income tax provision less than income tax payments
    		 -636,000,000   -526,000,000 -774,000,000 -752,000,000 -1,012,000,000 -433,000,000 -205,000,000   96,000,000 169,000,000    -123,000,000     -219,000,000 -131,000,000         -237,000,000 -117,000,000 -113,000,000    -103,000,000               
      net cash used by investing activities
    		 1,631,000,000 -1,289,000,000 -671,000,000   -939,000,000 -1,256,000,000   -224,000,000 -133,000,000 -290,000,000 -4,876,000,000 -526,000,000 -112,000,000 50,000,000 -372,000,000 -1,832,000,000 -1,202,000,000  -3,156,000,000 -1,566,000,000 -203,000,000   -152,000,000         -1,259,000,000 -794,000,000 -719,000,000 -716,000,000 -1,352,000,000 -1,530,000,000   -87,000,000 906,000,000   4,409,000,000 -2,316,000,000 -2,444,000,000 -1,227,000,000 -2,000,000 -3,302,000,000 
      net decrease in total cash, cash equivalents and restricted cash
    		                                                     
      net increase in total cash and cash equivalents
    		  -1,510,000,000 864,000,000 79,000,000 -1,449,000,000 1,025,000,000 -333,000,000 2,350,000,000 2,395,000,000 -1,291,000,000 1,974,000,000 -99,000,000 -3,975,000,000 566,000,000 -509,000,000 -283,000,000   369,000,000 587,000,000    3,788,000,000                             
      net (gains) losses on marketable securities and other investments
    		        -68,000,000 -39,000,000              -79,000,000                              
      net cash provided (used) by investing activities from discontinued operations
    		                                                     
      repayment of debt of acquired company
    		            0                                         
      net cash (used) provided by investing activities from discontinued operations
    		                                                     
      net cash provided (used) by investing activities
    		        -618,000,000                         79,000,000 681,000,000            445,000,000       
      net cash (used) provided by financing activities from discontinued operations
    		                                                     
      net cash used by financing activities from discontinued operations
    		                                                     
      net cash used by investing activities from discontinued operations
    		                                                     
      income tax provision (less than) in excess of income tax payments
    		           -120,000,000         150,000,000     -295,000,000 -663,000,000         36,000,000 -47,000,000      -7,000,000           
      net incomees (gains) on marketable securities and other investments
    		            58,000,000 161,000,000             37,000,000                           
      impairment losses on marketable securities and other investments
    		                        42,000,000 60,000,000 9,000,000  20,000,000 11,000,000 9,000,000 14,000,000 15,000,000 5,000,000 143,000,000 34,000,000 32,000,000 43,000,000 63,000,000 39,000,000 55,000,000 41,000,000 65,000,000 10,000,000          
      income tax provision in excess of income tax payments
    		               272,000,000                        -112,000,000 86,000,000   54,000,000 -24,000,000 10,000,000 258,000,000  59,000,000 -34,000,000 195,000,000   
      payment of purchase consideration related to rf360 holdings
    		                                                     
      net decrease in total cash and cash equivalents
    		                      -2,706,000,000 -730,000,000                              
      non-cash portion of share-based compensation expense
    		                     296,000,000 309,000,000 294,000,000 246,000,000 222,000,000 230,000,000  189,000,000 222,000,000 248,000,000 202,000,000 227,000,000 246,000,000 239,000,000 213,000,000 236,000,000 247,000,000 247,000,000 233,000,000 271,000,000 249,000,000 273,000,000 253,000,000 274,000,000 250,000,000 282,000,000 274,000,000 281,000,000 267,000,000 283,000,000 283,000,000 264,000,000 
      changes in cash and cash equivalents held for sale
    		                          -25,000,000                    -4,000,000 0 -46,000,000 18,000,000 13,000,000   
      payment of purchase consideration related to rf360 joint venture
    		                            -42,000,000                         
      reconciliation to the condensed consolidated balance sheets
    		                                                     
      cash and cash equivalents
    		                        3,788,000,000 69,000,000 10,066,000,000                           
      restricted cash and restricted cash equivalents included in other assets
    		                                                     
      net decrease in cash, cash equivalents, restricted cash and restricted cash equivalents
    		                          -1,711,000,000                           
      cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period
    		                          11,777,000,000                           
      cash, cash equivalents, restricted cash and restricted cash equivalents at end of period
    		                          10,066,000,000                           
      total cash, cash equivalents, restricted cash and restricted cash equivalents at end of period
    		                          10,066,000,000                           
      cash, cash equivalents and marketable securities
    		                                                     
      short-term debt
    		                                                     
      long-term debt
    		                                                     
      net cash from investing activities
    		                                                     
      net cash (used) provided by financing activities
    		                           -25,150,000,000                    -3,312,000,000 -1,272,000,000     
      income tax provision in excess of
    		                            -504,000,000 -220,000,000 5,697,000,000                       
      net realized gains on marketable securities and other investments
    		                            -28,000,000 -50,000,000 -23,000,000 -155,000,000 -139,000,000 -89,000,000 -147,000,000 -146,000,000 -69,000,000 -24,000,000 -49,000,000 -101,000,000 -122,000,000 -111,000,000 -166,000,000 -141,000,000 -297,000,000 -243,000,000 -145,000,000 -130,000,000 -60,000,000 -83,000,000 -96,000,000 -155,000,000 -70,000,000 
      purchases of available-for-sale marketable securities
    		                            -77,000,000 -131,000,000 -5,627,000,000  -6,707,000,000 -4,685,000,000 -4,117,000,000                   
      proceeds from sales and maturities of available-for-sale securities
    		                            1,446,000,000 4,955,000,000 2,704,000,000     4,083,000,000 4,497,000,000 2,693,000,000 3,113,000,000 3,183,000,000 3,266,000,000 4,053,000,000 4,578,000,000 3,843,000,000 4,060,000,000 3,516,000,000 2,168,000,000       
      purchases of other marketable securities
    		                               -5,000,000            0          
      deposits of investments designated as collateral
    		                               0 0                     
      deposit to redeem long-term debt
    		                                                     
      net increase in cash and cash equivalents
    		                            -2,327,000,000 4,584,000,000 -1,667,000,000 20,120,000,000 7,785,000,000 239,000,000 939,000,000 61,000,000    -2,427,000,000 4,495,000,000 -833,000,000 -1,582,000,000 -37,000,000 1,607,000,000 -1,955,000,000 2,150,000,000   -200,000,000 486,000,000 395,000,000 -2,586,000,000 
      cash and cash equivalents at beginning of period
    		                            0 0 35,029,000,000 0 0 0 5,946,000,000 0 0 0 7,560,000,000 0 0 0 7,907,000,000  0 0 6,142,000,000  0 0 3,807,000,000  0 
      cash and cash equivalents at end of period
    		                            -2,327,000,000 4,584,000,000 33,362,000,000 20,120,000,000 7,785,000,000 239,000,000 6,885,000,000 61,000,000 110,000,000 -1,138,000,000 6,913,000,000 -2,427,000,000 4,495,000,000 -833,000,000 6,325,000,000  1,607,000,000 -1,955,000,000 8,292,000,000  -1,560,000,000 -200,000,000 4,293,000,000  -2,586,000,000 
      interest expense in excess of interest payments
    		                                                     
      gain on sale of wireless spectrum
    		                                   0 0               0  
      incremental tax benefits from share-based compensation
    		                               -2,000,000 -1,000,000 -2,000,000 -35,000,000 -5,000,000 -1,000,000 0 -2,000,000 -5,000,000 -20,000,000 -30,000,000 -48,000,000  -70,000,000 -70,000,000 -99,000,000  -75,000,000 -42,000,000 -61,000,000   
      purchases of available-for-sale securities
    		                                   -5,055,000,000 -5,185,000,000 -4,038,000,000 -3,737,000,000 -2,282,000,000 -4,360,000,000 -2,792,000,000 -5,966,000,000 -3,266,000,000 -2,488,000,000 -5,772,000,000 -2,055,000,000 -1,839,000,000 -4,663,000,000 -4,160,000,000 -3,289,000,000 -3,707,000,000 -4,768,000,000 
      purchases of trading securities
    		                                   0 0 -28,000,000 -149,000,000 -126,000,000 -339,000,000 -393,000,000 -302,000,000 -207,000,000 -1,054,000,000 -1,029,000,000 -785,000,000 -654,000,000 -862,000,000 -826,000,000 -970,000,000 -1,729,000,000 -641,000,000 
      proceeds from sales and maturities of trading securities
    		                                   0 23,000,000 635,000,000 121,000,000 650,000,000 298,000,000 414,000,000 296,000,000 205,000,000 826,000,000 1,020,000,000 773,000,000       
      proceeds from sales and maturities of other marketable securities
    		                                                     
      proceeds from sale of wireless spectrum
    		                                   0 0 0 232,000,000             0  
      net cash provided (used) by financing activities
    		                               -1,122,000,000                      
      proceeds from sales and maturities of available-for-sale marketable securities
    		                                6,497,000,000 6,255,000,000 6,891,000,000                   
      proceeds from sales of other marketable securities
    		                                   0 0 250,000,000 200,000,000               
      deposit of investments designated as collateral
    		                                  -1,950,000,000                   
      gain on sale of discontinued operations
    		                                           0 0 0 -665,000,000       
      proceeds from sale of discontinued operations, net of cash sold
    		                                           0 0 0 788,000,000       
      net decrease in cash and cash equivalents
    		                                     -1,138,000,000 -647,000,000               
      realized gain on sale of wireless spectrum
    		                                      -380,000,000               
      long-lived asset and goodwill impairment charges
    		                                        166,000,000 63,000,000 75,000,000 0          
      change in obligations under securities lending
    		                                                     
      incremental tax benefit from share-based compensation
    		                                                     
      borrowings under loans and debentures
    		                                                     
      repayments of loans and debentures
    		                                                     
      effect of exchange rate changes on cash
    		                                                   5,000,000 -19,000,000 
      cash and cash equivalents at beginning of year
    		                                                     
      cash and cash equivalents at end of year
    		                                                     
      revenues related to non-monetary exchanges
    		                                              -31,000,000 -30,000,000 -31,000,000 -31,000,000 -31,000,000 -30,000,000 -31,000,000 
      borrowing under loans and debentures
    		                                                     
      repayment of loans and debentures
    		                                                     
      goodwill and long-lived asset impairment charges
    		                                             19,000,000 460,000,000       
      net impairment losses on marketable securities and other investments
    		                                             122,000,000 37,000,000    10,000,000   
      changes in assets and liabilities, net of effects of acquisitions:
    		                                                     
      depreciation and amortization
    		                                                255,000,000 248,000,000 241,000,000 257,000,000 221,000,000 
      proceeds from sales of available-for-sale securities
    		                                                2,805,000,000 2,306,000,000 2,226,000,000   
      proceeds from sales of trading securities
    		                                                767,000,000 574,000,000 1,024,000,000   
      change in obligation under securities lending
    		                                                  3,000,000   
      gains on derivative instruments
    		                                                    -13,000,000 
      repayment of loans
    		                                                     
      losses (gains) on derivative instruments
    		                                                  1,000,000   
      goodwill impairment
    		                                                   0 7,000,000 
      incremental tax benefit from stock options exercised
    		                                                   -41,000,000 -29,000,000 
      (gains) losses on derivative instruments
    		                                                     
      advance payment on spectrum
    		                                                     
      proceeds from sale of available-for-sale securities
    		                                                   4,084,000,000 2,231,000,000 
      proceeds from sale of trading securities
    		                                                   1,763,000,000 646,000,000 
      repayments of loans
    		                                                     
      proceeds from issuance of subsidiary shares to noncontrolling interests
    		                                                     
      repurchase and retirement of common stock
    		                                                   -841,000,000 -373,000,000 
      proceeds from issuance of subsidiary shares to noncontrolling interest
    		                                                     
      net cash from financing activities
    		                                                    -187,000,000 
      gain on sale of spectrum
    		                                                     
      proceeds from sale of spectrum
    		                                                     
      borrowing under loans payable
    		                                                     
      repayment of loans payable
    		                                                     
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.